Poseida Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Poseida Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2020 to Q3 2024.
  • Poseida Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $19.1M, a 15.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19.1M -$3.52M -15.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $20M -$3.43M -14.7% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $20.9M -$3.35M -13.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $21.7M -$3.36M -13.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $22.6M -$4.43M -16.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $23.4M -$4.59M -16.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $24.2M -$4.74M -16.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $25.1M -$1.09M -4.17% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $27M +$1.81M +7.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $28M +$1.91M +7.33% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $28.9M +$2.01M +7.45% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $26.2M +$1.19M +4.77% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $25.2M +$117K +0.47% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $26.1M +$5.92M +29.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $26.9M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $25M Dec 31, 2020 10-K 2022-03-10
Q3 2020 $25.1M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $20.1M Jun 30, 2020 10-Q 2020-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.